HUNTINGTON BANCSHARES INC (HBAN)

US4461501045 - Common Stock

16.46  +0.18 (+1.11%)

After market: 16.46 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HBAN. HBAN was compared to 407 industry peers in the Banks industry. HBAN may be in some trouble as it scores bad on both profitability and health. HBAN has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

HBAN had positive earnings in the past year.
In the past year HBAN had a positive cash flow from operations.
HBAN had positive earnings in each of the past 5 years.
Each year in the past 5 years HBAN had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.76%, HBAN is in line with its industry, outperforming 46.42% of the companies in the same industry.
With a Return On Equity value of 7.37%, HBAN perfoms like the industry average, outperforming 44.20% of the companies in the same industry.
Industry RankSector Rank
ROA 0.76%
ROE 7.37%
ROIC N/A
ROA(3y)0.93%
ROA(5y)0.92%
ROE(3y)9.12%
ROE(5y)8.84%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

HBAN's Profit Margin of 21.22% is in line compared to the rest of the industry. HBAN outperforms 45.19% of its industry peers.
In the last couple of years the Profit Margin of HBAN has declined.
HBAN does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 21.22%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y18.35%
PM growth 5Y-3.39%
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

HBAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
HBAN has more shares outstanding than it did 1 year ago.
HBAN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for HBAN is higher compared to a year ago.

2.2 Solvency

HBAN has a debt to FCF ratio of 11.20. This is a negative value and a sign of low solvency as HBAN would need 11.20 years to pay back of all of its debts.
HBAN has a Debt to FCF ratio of 11.20. This is in the lower half of the industry: HBAN underperforms 71.60% of its industry peers.
HBAN has a Debt/Equity ratio of 0.57. This is a neutral value indicating HBAN is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.57, HBAN is not doing good in the industry: 78.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 11.2
Altman-Z N/A
ROIC/WACCN/A
WACC13.63%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

3

3. Growth

3.1 Past

The earnings per share for HBAN have decreased strongly by -20.39% in the last year.
The Earnings Per Share has been growing slightly by 3.13% on average over the past years.
HBAN shows a decrease in Revenue. In the last year, the revenue decreased by -5.89%.
Measured over the past years, HBAN shows a quite strong growth in Revenue. The Revenue has been growing by 10.29% on average per year.
EPS 1Y (TTM)-20.39%
EPS 3Y25.99%
EPS 5Y3.13%
EPS Q2Q%-8.33%
Revenue 1Y (TTM)-5.89%
Revenue growth 3Y15.19%
Revenue growth 5Y10.29%
Sales Q2Q%-0.05%

3.2 Future

The Earnings Per Share is expected to grow by 2.20% on average over the next years.
Based on estimates for the next years, HBAN will show a small growth in Revenue. The Revenue will grow by 3.02% on average per year.
EPS Next Y-12.99%
EPS Next 2Y-1.1%
EPS Next 3Y3.43%
EPS Next 5Y2.2%
Revenue Next Year-0.65%
Revenue Next 2Y2.37%
Revenue Next 3Y3.15%
Revenue Next 5Y3.02%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.60, which indicates a correct valuation of HBAN.
HBAN's Price/Earnings is on the same level as the industry average.
HBAN is valuated cheaply when we compare the Price/Earnings ratio to 27.54, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.02, HBAN is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HBAN is on the same level as its industry peers.
HBAN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.6
Fwd PE 12.02

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, HBAN is valued a bit more expensive than the industry average as 70.37% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 22.71
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)4.34
EPS Next 2Y-1.1%
EPS Next 3Y3.43%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.90%, HBAN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.21, HBAN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, HBAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.9%

5.2 History

The dividend of HBAN has a limited annual growth rate of 5.35%.
HBAN has been paying a dividend for at least 10 years, so it has a reliable track record.
HBAN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.35%
Div Incr Years0
Div Non Decr Years15

5.3 Sustainability

HBAN pays out 68.97% of its income as dividend. This is not a sustainable payout ratio.
The dividend of HBAN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP68.97%
EPS Next 2Y-1.1%
EPS Next 3Y3.43%

HUNTINGTON BANCSHARES INC

NASDAQ:HBAN (12/24/2024, 8:18:34 PM)

After market: 16.46 0 (0%)

16.46

+0.18 (+1.11%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-17 2024-10-17/bmo
Earnings (Next)01-17 2025-01-17/amc
Inst Owners85.57%
Inst Owner Change1.03%
Ins Owners1.07%
Ins Owner Change-0.17%
Market Cap23.91B
Analysts76.3
Price Target18.34 (11.42%)
Short Float %2.12%
Short Ratio2.19
Dividend
Industry RankSector Rank
Dividend Yield 3.9%
Dividend Growth(5Y)5.35%
DP68.97%
Div Incr Years0
Div Non Decr Years15
Ex-Date12-18 2024-12-18 (0.155)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.59%
Min EPS beat(2)4.87%
Max EPS beat(2)8.31%
EPS beat(4)4
Avg EPS beat(4)8.23%
Min EPS beat(4)4.87%
Max EPS beat(4)9.94%
EPS beat(8)8
Avg EPS beat(8)6.22%
EPS beat(12)9
Avg EPS beat(12)1.85%
EPS beat(16)11
Avg EPS beat(16)2.27%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-1.63%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.73%
Min Revenue beat(4)-3.99%
Max Revenue beat(4)-0.63%
Revenue beat(8)1
Avg Revenue beat(8)-1.1%
Revenue beat(12)3
Avg Revenue beat(12)-1.08%
Revenue beat(16)4
Avg Revenue beat(16)-0.66%
PT rev (1m)7.66%
PT rev (3m)10.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.45%
EPS NY rev (1m)0.33%
EPS NY rev (3m)1.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.39%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 13.6
Fwd PE 12.02
P/S 3.34
P/FCF 22.71
P/OCF 19.46
P/B 1.16
P/tB 1.66
EV/EBITDA N/A
EPS(TTM)1.21
EY7.35%
EPS(NY)1.37
Fwd EY8.32%
FCF(TTM)0.72
FCFY4.4%
OCF(TTM)0.85
OCFY5.14%
SpS4.92
BVpS14.18
TBVpS9.92
PEG (NY)N/A
PEG (5Y)4.34
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 7.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 21.22%
GM N/A
FCFM 14.72%
ROA(3y)0.93%
ROA(5y)0.92%
ROE(3y)9.12%
ROE(5y)8.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y18.35%
PM growth 5Y-3.39%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 11.2
Debt/EBITDA N/A
Cap/Depr 24.04%
Cap/Sales 2.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 69.37%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC13.63%
ROIC/WACCN/A
Cap/Depr(3y)41.64%
Cap/Depr(5y)37.02%
Cap/Sales(3y)2.99%
Cap/Sales(5y)2.75%
Profit Quality(3y)158.46%
Profit Quality(5y)150.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.39%
EPS 3Y25.99%
EPS 5Y3.13%
EPS Q2Q%-8.33%
EPS Next Y-12.99%
EPS Next 2Y-1.1%
EPS Next 3Y3.43%
EPS Next 5Y2.2%
Revenue 1Y (TTM)-5.89%
Revenue growth 3Y15.19%
Revenue growth 5Y10.29%
Sales Q2Q%-0.05%
Revenue Next Year-0.65%
Revenue Next 2Y2.37%
Revenue Next 3Y3.15%
Revenue Next 5Y3.02%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.48%
EBIT Next 3Y10.04%
EBIT Next 5YN/A
FCF growth 1Y-63.84%
FCF growth 3Y27.87%
FCF growth 5Y9.27%
OCF growth 1Y-61.19%
OCF growth 3Y26.17%
OCF growth 5Y9.01%